Cannon, L., Wenderfer, S., Lewandowski, L., Cooper, J., Goilav, B., Knight, A., … Sadun, R. (2021). Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-Onset Systemic Lupus Erythematosus in North America. In ARTHRITIS & RHEUMATOLOGY (Vol. 73, pp. 1606–1609).

Cannon, Laura, Scott Wenderfer, Laura Lewandowski, Jennifer Cooper, Beatrice Goilav, Andrea Knight, Aimee Hersh, Stacy Ardoin, and Rebecca Sadun. “Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-Onset Systemic Lupus Erythematosus in North America.” In ARTHRITIS & RHEUMATOLOGY, 73:1606–9, 2021.

Cannon L, Wenderfer S, Lewandowski L, Cooper J, Goilav B, Knight A, et al. Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-Onset Systemic Lupus Erythematosus in North America. In: ARTHRITIS & RHEUMATOLOGY. 2021. p. 1606–9.

Cannon, Laura, et al. “Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-Onset Systemic Lupus Erythematosus in North America.” ARTHRITIS & RHEUMATOLOGY, vol. 73, 2021, pp. 1606–09.

Cannon L, Wenderfer S, Lewandowski L, Cooper J, Goilav B, Knight A, Hersh A, Ardoin S, Sadun R. Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-Onset Systemic Lupus Erythematosus in North America. ARTHRITIS & RHEUMATOLOGY. 2021. p. 1606–1609.